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Abstract: A post hoc analysis was made to identify factors associated with success following a 4-month telephone-based 
strategy for enhancing adherence to antipsychotic treatment in schizophrenia. A total of 928 stable outpatients were   
randomized to receive a monthly telephone call provided by a nurse or routine clinical care. Logistic regression with a 
backward stepwise procedure was used. A higher percentage of patients in the intervention group (25.7%, n=109)   
improved adherence at the end of the study compared with the control group (16.8%, n=74) (p=0.0013). The intervention 
was significantly associated with adherence improvement in those patients with a previous negative attitude towards 
medication (OR=4.7, 95% CI =2.4-9.0, p<0.0001). A slight concordance was obtained between adherence improvement 
and improvement in patient perception of treatment (kappa=0.21; 95% CI=0.15-0.27). The identification of factors related 
to the effectiveness of a specific intervention would offer clinicians the opportunity to more adequately select patients 
who are eligible for such intervention. 
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FINDINGS 
Antipsychotic medication is the primary treatment   
modality for acute episodes as well as for relapse prevention 
in schizophrenia [1]. However, the full benefits of   
medication as demonstrated by clinical research trials have 
failed to become implemented in routine clinical care. Poor 
adherence to medication is thought to be a significant obsta-
cle in achieving this goal [2, 3]. Up to 75% of patients with 
schizophrenia discontinued treatment within two years   
of hospital discharge [4]. Non-adherence to treatment is   
associated with poorer clinical and functional outcomes,   
increased use of emergency psychiatric services, and an   
increased number of hospitalizations [5].  
Many intervention strategies have been used to improve 
medication adherence in patients with schizophrenia [6]. In a 
recently  published randomized, controlled, four-month 
study, an intervention based on a telephone call provided by 
a mental health nurse once monthly proved effective in en-
hancing oral antipsychotic adherence among patients with 
schizophrenia [7].  
Non-adherence may be determined by many factors that 
could contribute to maintain patients in this situation even 
after intervention for improving adherence [2]. Identifying 
risk factors associated with failure after a specific interven-
tion for enhancing adherence in patients with schizophrenia 
would allow improvement of the intervention. On the other 
hand, the identification of factors related to the success of a 
specific intervention would offer clinicians the opportunity  
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to more adequately select patients who are eligible for such 
intervention. 
We performed a post hoc analysis using data from the 
aforementioned study [7]. The aim was to identify factors 
associated with success following a 4-month telephone-
based nursing strategy for improving adherence to mainte-
nance antipsychotic treatment in patients with schizophrenia. 
The study was conducted in 198 community mental 
health centers throughout Spain. Ethical approval was ob-
tained from the Fundació Catalana d´Hospitals (Barcelona, 
Spain). Data were collected from October 2006 to November 
2007. After complete description of the study to the partici-
pants, written informed consent was obtained. The sample 
population for analysis comprised a total of 865 clinically 
stable outpatients having a DSM-IV-TR diagnosis of schizo-
phrenia, being at least 18 years old, and taking a single oral 
antipsychotic drug. Their mean age was 40.08 years (SD 
11.6), and 65.3% were males. The mean baseline Clinical 
Global Impression - Severity score was 3.2 (SD 1.2). The 
patients randomized to the intervention group (n=424) re-
ceived a standardized telephone call made by a nurse at 
weeks 4, 8, and 12. Patients assigned to the control group 
(n=441) were scheduled for the final visit four months after 
inclusion, without telephone calls, and emulating the usual 
period of clinical care among stable outpatients with schizo-
phrenia in Spain. Each telephone call consisted of a brief 
semi-structured assessment of medication adherence (a series 
of questions inquired about knowledge of the medication 
regimen and episodes of missed doses or incomplete adher-
ence). In addition, the interview included the Drug Attitude 
Inventory in its 10-item version (DAI-10) [8]. Nurses re-
ceived specific training for the study from investigators be-
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Adherence to antipsychotic treatment was evaluated by 
the treating psychiatrist and the nurse according to the Regis-
ter of Adherence to Treatment scale (RAT): high (adherence 
with 80% of doses), moderate (adherence with 60-79% of 
doses), low (adherence with 20-59% of doses), and nil (ad-
herence with < 20% of doses) [7]. For the analysis, an im-
provement in adherence to treatment was considered when a 
patient was at least in an immediately higher level of adher-
ence according to the RAT at the end of the study compared 
to baseline (e.g., moderate adherence at the end of study vs. 
low adherence at baseline). 
A significantly higher percentage of patients in the inter-
vention group (25.7%, n=109) improved adherence to treat-
ment at the end of the study compared with the control group 
(16.8%, n=74) (p=0.0013).  
To explore factors which could be related to improve-
ment in adherence after the intervention, socio-demographic 
and clinical characteristics of the patients who improved 
their adherence status were compared with those who did 
not. No significant differences were observed in terms of 
age, gender, living status, education, marital and occupa-
tional status, schizophrenia subtypes, number of hospitaliza-
tions, class of antipsychotic drug (typical vs. atypical) or 
previous psychoeducation received. On the other hand, a 
significantly shorter duration of illness (11.6 vs. 13.5 years; 
p=0.0196), a greater number of previous acute episodes (2.3 
vs. 1.6; p<0.0001), and shorter periods of time from the last 
acute episode (1.9 vs. 3.5 years; p<0.0001) or from last hos-
pitalization (2.9 vs. 4.9 years; p<0.0001) were observed in 
those patients who improved their adherence status at the 
end of the study compared to those patients who did not ex-
perience improvement. Taking into account the bivariate 
analysis described above, a multivariate analysis (logistic 
regression) was performed to more adequately identify out-
come predictors for improvement in adherence. Socio-
demographic and clinical variables were introduced in the 
model as independent variables, with improved adherence as 
the dependent variable. After backward stepwise elimination 
of the non-significant variables (p>0.05), the following vari-
ables remained in the model: group of study (intervention vs. 
control, OR= 1.86, 95% CI=1.31-2.65, p=0.0006) and base-
line DAI-10 score (negative [score <0] vs. positive attitude 
towards medication [score >0], OR= 5.57, 95% CI=3.83-
8.11, p<0.0001). The odds ratio for improvement in adher-
ence with the intervention was calculated in those patients 
with baseline negative and positive attitudes towards medi-
cation. The telephone-based nursing intervention was sig-
nificantly associated with improved adherence in those pa-
tients with a previous negative perception of treatment 
(OR=4.7, CI 95 %=2.4-9.0, p<0.0001), but there was no sig-
nificant association in those patients with a previous positive 
perception (OR=1.2, 95% CI =0.8-1.9, p=0.3628) (Fig. 1). A 
kappa index was obtained to assess the concordance between 
the improvement in adherence after the intervention and im-
provement in patient perceptions of treatment. A slight con-
cordance was observed between these two variables (k=0.21; 
95% CI=0.15-0.27). 
The principal findings from these analyses demonstrate 
that the intervention was significantly more effective in those 
patients with a previous negative perception of treatment 
compared to those with a good perception. 
The critical importance of optimal adherence to pre-
scribed antipsychotic treatments has been convincingly dem-
onstrated in patients with schizophrenia [4]. Positive attitude 
towards medication, as measured by the DAI-10, is associ-
ated with significantly higher adherence rates [9].  
This study suggests that adherence can be improved with 
an intervention even in those patients with a risk factor con-
sistently associated to non-adherence, such as a negative 
attitude towards medication. Furthermore, when a bad per-
ception of antipsychotic treatment is detected in a patient, 
this telephone intervention could be applied in order to en-
hance adherence and, subsequently, to improve the outcome.  
Improvement in adherence after the intervention in those 
patients with a baseline negative perception of treatment 
could be partially explained by improvement in their attitude 
towards medication. A slight concordance was observed be-
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tween these two variables, suggesting that in some patients 
the telephone call improved the perception of antipsychotic 
treatment. Alternatively, in those patients who enhanced 
adherence without improving their attitude towards medica-
tion, the intervention could be acting as a reminder, increas-
ing the number of days patients are taking the medication as 
prescribed. We can hypothesize that patients increasing ad-
herence will improve their attitude towards medication over 
the long term, as a consequence of their psychopathological 
improvement.  
A limitation of this analysis was the lack of assessment 
of some factors consistently related to non-adherence. A 
measure for insight was lacking in the study and factors re-
lated to medication, with the exception of the class of antip-
sychotic drug, were not systematically assessed. In addition, 
other environmental factors that are emerging as being pre-
dictive of non-adherence, including a poor alliance with the 
therapist or clinician, or less outpatient contact, were not 
assessed [10]. Consequently, the benefit of the intervention 
in non-adherent patients presenting these risk factors may 
not be established.  
In summary, the results of this analysis reveal that a tele-
phone call made by a mental health nurse is a successful 
intervention for enhancing adherence in stable patients with 
schizophrenia. This intervention could be especially useful 
for improving adherence in those patients with a negative 
attitude towards antipsychotic treatment.  
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